A Colombian businessman was carrying a letter from Venezuelan President Nicolas Maduro accrediting him to Iran’s supreme leader when he was arrested on a U.S. warrant last year in the African nation of Cape Verde
Press release content from Business Wire. The AP news staff was not involved in its creation.
Kaman Announces New Order for the K-MAX® Helicopter
January 20, 2021 GMT
BLOOMFIELD, Conn. (BUSINESS WIRE) Jan 20, 2021
Kaman Air Vehicles, a division of Kaman Corporation (NYSE:KAMN), announced today the receipt of a signed purchase agreement for a K-MAX
® medium-to-heavy lift helicopter. Delivery of this aircraft is expected in the first quarter of 2021 and follows the delivery of two aircraft in the fourth quarter of 2020. We continue to see demand and interest in the capabilities of the K-MAX
® across multiple markets.
“We are excited for the opportunity to deliver our third K-MAX
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine
Gritstone Oncology, IncJanuary 20, 2021 GMT Deal provides nonexclusive access to Genevant’s leading LNP technology for use in Gritstone’s self-amplifying RNA COVID-19 vaccine program; NIH-sponsored Phase 1 clinical trial expected to initiate in 1Q21 Agreement is the second between the parties since October 2020
EMERYVILLE, Calif. and VANCOUVER, British Columbia and BASEL, Switzerland , Jan. 20, 2021 (GLOBE NEWSWIRE) Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, and Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, today announced an agreement pursuant to whi
Press release content from Business Wire. The AP news staff was not involved in its creation.
InClin Announces Quasar Publication Featuring First Virtual Inspection Conducted by the European Medicines Agency (EMA)
January 20, 2021 GMT
SAN MATEO, Calif. (BUSINESS WIRE) Jan 20, 2021
InClin, Inc., a full-service Contract Research Organization (CRO) with offices in the San Francisco Bay Area and Sydney, Australia, today announced the publication of a manuscript entitled: “The New Norm: A Global Virtual GCP Preapproval EMA Inspection” in Issue #154 January 2021 edition of Quasar, the Research Quality Association’s (RQA) quarterly journal.
The article describes how the European Medicines Agency (EMA) and sponsor collaborated to successfully complete a global, fully virtual, and remote EMA inspection, the first of its kind. Ultimately, a robust plan, flexibility, and innovative use of appropriate resources, logistics, and electronic tools were key components of the successful EM